S. Sanjar

发表

Mast cell tryptase stimulates human lung fibroblast proliferation via protease-activated receptor-2.

M. Hollenberg, G. Laurent, M. Parsons, 2000, American journal of physiology. Lung cellular and molecular physiology.

Effect of smoking status on lung function, patient-reported outcomes, and safety among patients with COPD treated with indacaterol/glycopyrrolate: Pooled analysis of the FLIGHT1 and FLIGHT2 studies.

D. Tashkin, Sanjay Sharma, A. Ozol-Godfrey, 2019, Respiratory medicine.

Improvement in Lung Function and Patient-Reported Outcomes in Patients with COPD with Comorbid Anxiety and Depression Receiving Nebulized Glycopyrrolate in the GOLDEN 3 and 4 Studies

A. Yohannes, N. Hanania, Sanjay Sharma, 2021, International journal of chronic obstructive pulmonary disease.

Efficacy of Nebulized Glycopyrrolate on Lung Hyperinflation in Patients with COPD

T. Siler, Sanjay Sharma, K. Sciarappa, 2021, Pulmonary Therapy.

The Effect of Baseline Rescue Medication Use on Efficacy and Safety of Nebulized Glycopyrrolate Treatment in Patients with COPD from the GOLDEN 3 and 4 Studies

J. Donohue, A. Ozol-Godfrey, S. Sanjar, 2020, International journal of chronic obstructive pulmonary disease.

Effect of smoking status on lung function, patient-reported outcomes, and safety among COPD patients treated with glycopyrrolate inhalation powder: pooled analysis of GEM1 and GEM2 studies

D. Tashkin, Sanjay Sharma, A. Ozol-Godfrey, 2019, Respiratory Research.

Dual Bronchodilation with Indacaterol Maleate/Glycopyrronium Bromide Compared with Umeclidinium Bromide/Vilanterol in Patients with Moderate-to-Severe COPD: Results from Two Randomized, Controlled, Cross-over Studies

E. Kerwin, S. Maitra, R. Fogel, 2017, Lung.

In vivo method for the assessment of platelet accumulation.

S. Sanjar, J. Morley, C. Herd, 1989, Journal of pharmacological methods.

Impact of baseline clinical features on outcomes of nebulized glycopyrrolate therapy in COPD

D. Tashkin, Sanjay Sharma, S. Sanjar, 2021, npj Primary Care Respiratory Medicine.

Effect of Gender on Lung Function and Patient-Reported Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate

J. Ohar, A. Ozol-Godfrey, S. Sanjar, 2020, International journal of chronic obstructive pulmonary disease.

The Effect of Metabolic Syndrome Status on Lung Function and Patient-reported Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate.

B. Carlin, A. Ozol-Godfrey, G. Ferguson, 2020, Chronic obstructive pulmonary diseases.

COPD_A_242767 745..754

J. Donohue, A. Ozol-Godfrey, S. Sanjar, 2020 .

Suppression of Paf-acether responses: An anti-inflammatory effect of anti-asthma drugs

C. Page, S. Sanjar, J. Morley, 1985, Agents and Actions.

THE PLATELET IN ASTHMA

C. Page, S. Sanjar, J. Morley, 1984, The Lancet.

Evidence that neutrophils do not participate in the late-phase airway response provoked by ovalbumin inhalation in conscious, sensitized guinea pigs.

S. Holgate, M. Church, S. Sanjar, 1990, The American review of respiratory disease.

Viewpoint: untoward effects of beta-adrenoceptor agonists in asthma.

C. Newth, S. Sanjar, J. Morley, 1990, The European respiratory journal.

Effect of Gender on Lung Function and Patient-Reported Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate

J. Ohar, A. Ozol-Godfrey, S. Sanjar, 2019, International journal of chronic obstructive pulmonary disease.

Effects of serum albumin, indomethacin and histamine H1‐antagonists on Paf‐acether‐induced inflammatory responses in the skin of experimental animals and man

D. Macdonald, C. Page, C. Archer, 1985, British journal of pharmacology.

Effects of ketotifen upon responses to platelet activating factor: a basis for asthma prophylaxis.

C. Page, S. Sanjar, J. Morley, 1986, Annals of allergy.

PLATELETS AND ASTHMA

C. Page, S. Sanjar, J. Morley, 1985, The Lancet.

Temporal relationships between leukocytes, IL-5 and IL-8 in guinea pig lungs, plasma cortisol and airway function after antigen challenge

H. Danahay, K. Broadley, A. Nials, 1999, Inflammation Research.

A simple, rapid, and sensitive scintillation proximity assay for the determination of levels of guinea-pig interleukin-5 in bronchoalveolar lavage samples.

H. Danahay, K. Broadley, A. Nials, 1997, Journal of pharmacological and toxicological methods.

The effect of prophylactic anti-asthma drugs on PAF-induced airway hyperreactivity.

S. Sanjar, J. Morley, L. Mazzoni, 1989, Japanese journal of pharmacology.

Eosinophil accumulation in pulmonary airways of guinea‐pigs induced by exposure to an aerosol of platelet‐activating factor: effect of anti‐asthma drugs

S. Sanjar, J. Morley, K. Boubekeur, 1990, British journal of pharmacology.

Inhibition of natural anti-inflammatory mechanism by β2-agonists

R. A. Coleman, M. Johnson, S. Sanjar, 1991, The Lancet.

Antigen challenge induces pulmonary airway eosinophil accumulation and airway hyperreactivity in sensitized guinea‐pigs: the effect of anti‐asthma drugs

S. Sanjar, J. Morley, D. Smith, 1990, British journal of pharmacology.

AIRWAY HYPERREACTIVITY

S. Sanjar, J. Morley, 1988, The Lancet.

Impact of Comorbidity Prevalence and Cardiovascular Disease Status on the Efficacy and Safety of Nebulized Glycopyrrolate in Patients with COPD

N. Putcha, Sanjay Sharma, A. Ozol-Godfrey, 2021, International journal of chronic obstructive pulmonary disease.

Effect of SGRQ-Defined Chronic Bronchitis at Baseline on Treatment Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate

D. Tashkin, Sanjay Sharma, A. Ozol-Godfrey, 2021, International journal of chronic obstructive pulmonary disease.

COPD_A_304182 945..955

D. Tashkin, Sanjay Sharma, A. Ozol-Godfrey, 2021 .

PAF antagonism in asthma

C. Page, S. Sanjar, J. Morley, 1985 .

Inflammatory Mediators of Asthma

C. Page, S. Sanjar, J. Morley, 1983, The Lancet.

Platelet activating factor (Paf-acether) may account for late-onset reactions to allergen inhalation

C. Page, S. Sanjar, J. Morley, 1985, Agents and Actions.

Pharmacological evaluation of prophylactic anti-asthma drugs by reference to the pathological sequelae of exposure to allergen or platelet activating factor.

S. Sanjar, J. Morley, K. Boubekeur, 1988, Agents and actions. Supplements.

The role of circulating cells in skin reactions

C. Page, S. Sanjar, J. Morley, 1985, The British journal of dermatology.

Pretreatment with rh‐GMCSF, but not rh‐IL3, enhances PAF‐induced eosinophil accumulation in guinea‐pig airways

S. Sanjar, J. Morley, D. Smith, 1990, British journal of pharmacology.

Human recombinant lymphokines and cytokines induce pulmonary eosinophilia in the guinea pig which is inhibited by ketotifen and AH 21-132.

S. Sanjar, J. Morley, M. Kings, 1990, International archives of allergy and applied immunology.

The effect of prophylactic anti-asthma drugs on PAF-induced platelet accumulation in the thorax of the guinea pig.

S. Sanjar, J. Morley, D. Smith, 1989, Japanese journal of pharmacology.

Efficacy and Safety of Nebulized Glycopyrrolate/eFlow® Closed System in Patients with Moderate-to-Very-Severe Chronic Obstructive Pulmonary Disease with Pre-Existing Cardiovascular Risk Factors.

G. Ferguson, R. Tosiello, S. Sanjar, 2018, Chronic obstructive pulmonary diseases.

In Vitro Effect of Different Airflow Rates on the Aerosol Properties of Nebulized Glycopyrrolate in the eFlow® Closed System and Tiotropium Delivered in the HandiHaler®

J. Ohar, Sanjay Sharma, S. Sanjar, 2020, Pulmonary Therapy.

Inhibition of PAF-induced eosinophil accumulation in pulmonary airways of guinea pigs by anti-asthma drugs.

L. Burrows, S. Sanjar, J. Morley, 1989, Japanese journal of pharmacology.

Treating systemic diseases via the lung.

S. Sanjar, J. Matthews, 2001, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

Effects ofserumalbumin, indomethacin andhistamine HI-antagonists onPaf-acether-indu ced inflammatory responsesintheskin ofexperimental animals andman

D. Macdonald, C. Page, C. Archer, 1985 .

PLATELETS IN ASTHMA

C. Page, S. Sanjar, J. Morley, 1985, The Lancet.

Increased airway reactivity in the guinea‐pig follows exposure to intravenous isoprenaline.

S. Sanjar, J. Morley, L. Mazzoni, 1990, The Journal of physiology.

Pharmacology of the late response to allergen and its relevance to asthma prophylaxis.

C. Page, S. Sanjar, J. Morley, 1985, International archives of allergy and applied immunology.

Agonist-induced adherence of equine eosinophils to fibronectin.

S. Sanjar, F. Cunningham, A. P. Foster, 1997, Veterinary immunology and immunopathology.

Maintenance of the Epithelial Barrier in a Bronchial Epithelial Cell Line is Dependent on Functional E-cadherin Local to the Tight Junctions

M. R. West, D. Ferguson, S. Sanjar, 2002, Cell communication & adhesion.

263 Neutrophils do not participate in the development of the late asthmatic reaction (LAR) in guinea-pigs

S. Holgate, M. Church, S. Sanjar, 1988 .

The severity of airway inflammation and goblet cell hyperplasia in a murine model of atopic asthma are directly related to allergen dose and are reduced by treatment with a glucocorticoid

S. Sanjar, M. Pedrick, D. I. Blyth, 1998 .

Neutrophil infiltration does not contribute to the ulcerogenic effects of indomethacin in the rat gastric antrum

P. Strong, M. Trevethick, S. Sanjar, 1994, Agents and Actions.

Neutrophil depletion does not prevent indomethacin-induced ulceration of the rat gastric antrum

P. Strong, M. Trevethick, S. Sanjar, 1994, Agents and Actions.

The preclinical pharmacology of roflumilast--a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease.

A. Hatzelmann, S. Adnot, G. Lungarella, 2010, Pulmonary pharmacology & therapeutics.

Induction, duration, and resolution of airway goblet cell hyperplasia in a murine model of atopic asthma: effect of concurrent infection with respiratory syncytial virus and response to dexamethasone.

J. Beesley, S. Sanjar, H. Bright, 1998, American journal of respiratory cell and molecular biology.

Airway subepithelial fibrosis in a murine model of atopic asthma: suppression by dexamethasone or anti-interleukin-5 antibody.

S. Sanjar, M. Pedrick, T. J. Savage, 2000, American journal of respiratory cell and molecular biology.

Loss of epithelial integrity resulting from E-cadherin dysfunction predisposes airway epithelial cells to adenoviral infection.

M. R. West, C. Ring, Y Man, 2000, American journal of respiratory cell and molecular biology.

Decreased distribution of lung epithelial junction proteins after intratracheal antigen or lipopolysaccharide challenge: correlation with neutrophil influx and levels of BALF sE-cadherin.

M. R. West, S. Sanjar, S. Evans, 2002, American journal of respiratory cell and molecular biology.

The Role of Inhalation Delivery Devices in COPD: Perspectives of Patients and Health Care Providers.

S. Braman, D. Mahler, N. Hanania, 2018, Chronic obstructive pulmonary diseases.

COMPARISON BETWEEN IN VITRO AND IN VIVO AGGREGATION OF PLATELETS

C. Tapparelli, S. Sanjar, J. Morley, 1987, Thrombosis and Haemostasis.

Efficacy of Indacaterol/Glycopyrrolate in Patients with COPD by Airway Reversibility at Baseline: A Pooled Analysis of the FLIGHT1 and FLIGHT2 12-Week Studies

J. Ohar, A. Ozol-Godfrey, S. Sanjar, 2019, COPD.

Efficacy and safety of glycopyrrolate in patients with COPD by reversibility: pooled analysis of GEM1 and GEM2 12-week studies

J. Ohar, A. Ozol-Godfrey, S. Sanjar, 2019, International journal of chronic obstructive pulmonary disease.

Effect of background long-acting beta2-agonist therapy on the efficacy and safety of a novel, nebulized glycopyrrolate in subjects with moderate-to-very-severe COPD

E. Kerwin, R. Tosiello, S. Sanjar, 2018, International journal of chronic obstructive pulmonary disease.

Implementing Digital Technologies in Clinical Trials: Lessons Learned.

G. Mitsi, A. Pikalov, T. Grinnell, 2022, Innovations in clinical neuroscience.

Efficacy and safety of a novel, nebulized glycopyrrolate for the treatment of COPD: effect of baseline disease severity and age; pooled analysis of GOLDEN 3 and GOLDEN 4

J. Ohar, R. Tosiello, S. Sanjar, 2018, International journal of chronic obstructive pulmonary disease.